Genmab — Marts 2017
-
Der er vist basis for et PI-møde i området ved lejlighed.

-
Har ikke adgang, men det koster kassen at udvikle medicin http://medwatch.dk/secure/Medicinal___Biotek/article9444515.ece?utm_source=Feed&utm_medium=latest
-
J&J-direktør: Genmab har udnyttet os på den bedst mulige måde
Genmab-midlet Darzalex har været på en raketagtig kurs mod himlen i en årrække nu, og en af direktørerne, der har ansvaret for onkologisk udvikling hos partneren J&J's innovationscenter i London, giver sit indblik i det, der har gjort forskellen i samarbejdet.
(medwatch.dk)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind